BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29359515)

  • 1. Bone marrow-derived mononuclear cell therapy for nonischaemic dilated cardiomyopathy-A meta-analysis.
    Wen Y; Ding J; Zhang B; Gao Q
    Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29359515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.
    Hamshere S; Arnous S; Choudhury T; Choudry F; Mozid A; Yeo C; Barrett C; Saunders N; Gulati A; Knight C; Locca D; Davies C; Cowie MR; Prasad S; Parmar M; Agrawal S; Jones D; Martin J; McKenna W; Mathur A
    Eur Heart J; 2015 Nov; 36(44):3061-9. PubMed ID: 26333366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy.
    Lu Y; Wang Y; Lin M; Zhou J; Wang Z; Jiang M; He B
    Stem Cell Res Ther; 2016 Dec; 7(1):186. PubMed ID: 27938412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).
    Martino H; Brofman P; Greco O; Bueno R; Bodanese L; Clausell N; Maldonado JA; Mill J; Braile D; Moraes J; Silva S; Bozza A; Santos B; Campos de Carvalho A;
    Eur Heart J; 2015 Nov; 36(42):2898-904. PubMed ID: 26392433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.
    Nso N; Bookani KR; Enoru ST; Radparvar F; Gordon R
    Heart Fail Rev; 2022 May; 27(3):811-820. PubMed ID: 33587248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplantation of bone marrow/blood-derived cells for chronic ischemic heart disease: a systematic review and meta-analysis.
    Xu R; Ding S; Zhao Y; Pu J; He B
    Can J Cardiol; 2014 Nov; 30(11):1370-7. PubMed ID: 24726092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Comparative Study on the Efficacy of Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells in Patients With Dilated Cardiomyopathy.
    Xiao W; Guo S; Gao C; Dai G; Gao Y; Li M; Wang X; Hu D
    Int Heart J; 2017 Apr; 58(2):238-244. PubMed ID: 28190794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure.
    Wen Y; Chen B; Wang C; Ma X; Gao Q
    Expert Opin Biol Ther; 2012 Dec; 12(12):1563-73. PubMed ID: 22953786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with dilated cardiomyopathy].
    CHEN Y; GAO EM; GAO CY; XU Y; HUANG KJ; NIU ZM; ZHU ZY; YANG HH; LI MW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1087-91. PubMed ID: 19134276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy.
    Pincott ES; Ridout D; Brocklesby M; McEwan A; Muthurangu V; Burch M
    J Heart Lung Transplant; 2017 Aug; 36(8):837-844. PubMed ID: 28162930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial.
    Sant'Anna RT; Fracasso J; Valle FH; Castro I; Nardi NB; Sant'Anna JR; Nesralla IA; Kalil RA
    Rev Bras Cir Cardiovasc; 2014; 29(3):437-47. PubMed ID: 25372920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial.
    San Roman JA; Sánchez PL; Villa A; Sanz-Ruiz R; Fernandez-Santos ME; Gimeno F; Ramos B; Arnold R; Serrador A; Gutiérrez H; Martin-Herrero F; Rollán MJ; Fernández-Vázquez F; López-Messa J; Ancillo P; Pérez-Ojeda G; Fernández-Avilés F
    J Am Coll Cardiol; 2015 Jun; 65(22):2372-82. PubMed ID: 26046730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGENERATE-DCM) trial: study design.
    Arnous S; Mozid A; Mathur A
    Regen Med; 2011 Jul; 6(4):525-33. PubMed ID: 21749209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathy.
    Lacis A; Erglis A
    Cardiol Young; 2011 Feb; 21(1):110-2. PubMed ID: 20977823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol.
    Romero M; Suárez-de-Lezo J; Herrera C; Pan M; López-Aguilera J; Suárez-de-Lezo J; Baeza-Garzón F; Hidalgo-Lesmes FJ; Fernández-López O; Martínez-Atienza J; Cebrián E; Martín-Palanco V; Jiménez-Moreno R; Gutiérrez-Fernández R; Nogueras S; Carmona MD; Ojeda S; Cuende N; Mata R
    BMC Cardiovasc Disord; 2019 Aug; 19(1):203. PubMed ID: 31438858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of intracoronary transplantation of autologous bone marrow cells in dilated cardiomyopathy].
    Bartolucci J; Verdugo FJ; Carrion F; Abarzúa E; Goset C; Lamich R; Sanhueza P; Pedreros P; Nazzal C; Khoury M; Figueroa FE
    Rev Med Chil; 2015 Apr; 143(4):415-23. PubMed ID: 26204531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation of bone marrow adult stem cells for the treatment of idiopathic dilated cardiomyopathy.
    Westphal RJ; Bueno RR; Galvão PB; Zanis Neto J; Souza JM; Guérios ÊE; Senegaglia AC; Brofman PR; Pasquini R; Cunha CL
    Arq Bras Cardiol; 2014 Dec; 103(6):521-9. PubMed ID: 25590932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study on the efficacy of intracoronary infusion with various types of autologous bone marrow stem cells for patients with dilated cardiomyopathy].
    Xiao WT; Gao LJ; Gao CY; Gao YJ; Dai GY; Li MW; Wang XP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jul; 40(7):575-8. PubMed ID: 22943685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.